Therefore, the up-regulated key TME-related genes SLC27A2, KLRB1, IGKV1OR2-108 and IGHV1-12 in the low-risk score group inhibit tumor progression by affecting the secretion of neutrophils, NK cells and immunoglobulin. Here, IGKV1OR-2 is linked to neoplasm.